Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]
Chen C +5 more
europepmc +1 more source
O1‐04‐04: A multicenter, double‐blind, placebo‐controlled phase IIb proof‐of‐concept dose‐ranging study of AZD3480 and donepezil over 12 weeks in patients with mild to moderate Alzheimer's disease [PDF]
Lutz Frölich +3 more
openalex +1 more source
Zinc-Modified Mordenite Zeolite as a Molecular Carrier for Donepezil: A Framework for Drug Delivery Applications. [PDF]
Guaya D +5 more
europepmc +1 more source
<i>Lactobacillus delbrueckii</i> subsp. <i>lactis</i> CKDB001 Ameliorates Scopolamine-Induced Cognitive Impairment Through Metabolic Modulation. [PDF]
Kim H +9 more
europepmc +1 more source
Switching from Donepezil or Rivastigmine to Galantamine in Clinical Practice [PDF]
Keith R. Edwards +2 more
openalex +1 more source
Novel Bioinspired Quercetin-Based Polymers for the Sustained Release of Donepezil in Alzheimer's Disease Therapy. [PDF]
Carreiro EP +5 more
europepmc +1 more source
The combination of donepezil and cognitive training for improving treatment outcomes for alcohol use disorder: Design of a randomized controlled trial [PDF]
Gihyun Yoon +4 more
openalex +1 more source
Evaluation of the safety and efficacy of a donepezil depot injection in dogs with canine cognitive dysfunction. [PDF]
Kang MH +6 more
europepmc +1 more source
Drug-Dependent Enhancement of Blood-Brain Barrier Permeation by Polysorbate 80 Minor Components. [PDF]
Wang X +7 more
europepmc +1 more source
Cognitive stimulation exerts long-lasting protective effects on the hippocampal vasculature and memory function in a rat model of vascular cognitive impairment. [PDF]
Chapman AC +8 more
europepmc +1 more source

